1. Aijaz Bilal
2. Bittner Vera

9789350252758

10.5005/jp/books/11124_45

1/e

2013

17

1. University of Alabama, USA
2. University of Alabama, USA

Cardiovascular disease, coronary heart disease, hypertension, Framingham risk score, Reynolds risk score, QRISK algorithm, peripheral arterial disease, C-reactive protein, European risk scores, myocardial infarction, receiver operating characteristic curve, high density lipoprotein cholesterol (HDL-C) levels, obesity, eicosapentaenoic acids, docosahexaenoic acids, obesity cardiomyopathy, dyslipidemia, arrhythmias, hyperlipidemia, enhancing recovery in coronary heart disease (ENRICHD) trial, diabetes, JUPITER trial, Lp(a), apoliporotein B, hyperhomocysteinemia, atherosclerosis, lipoprotein-associated phospholipase A2, thrombogenesis, endothelial dysfunction, plaque instability, adipocytes, adipocytokines